Plant-derived extracellular vesicles (PDEVs), including exosome-like nanovesicles (PELNVs), are gaining traction as alternative nanoscale delivery systems due to their natural origin, potential scalability, and reported biocompatibility in experimental models. However, their composition and functional properties can vary substantially with plant source, isolation method, and preparation conditions, posing challenges for researchers seeking reproducible results. Creative Biolabs has expanded its plant-derived EV research capabilities to address these challenges, offering custom services for the isolation, purification, characterization, cargo loading, and preclinical evaluation of vesicles derived from edible plant sources.
The expansion matters because it provides researchers with a systematic workflow to investigate PDEVs as biological nanoparticles and experimental delivery systems. Experimental studies have reported favorable biocompatibility and interactions with biological barriers, but these properties depend heavily on vesicle source, composition, preparation, and the experimental model. By offering tailored services for specific plant sources, Creative Biolabs enables more rigorous comparisons and applications. For instance, strawberry-derived EVs are being investigated in oxidative-stress, skin biology, and tissue-repair research, including studies examining antioxidant-associated cargos and cellular responses relevant to extracellular-matrix biology. Researchers interested in these applications can access Strawberry-derived EVs through the company's platform.
Similarly, grapefruit-derived EVs have been explored for oral-delivery applications, including studies of vesicle stability under gastrointestinal conditions and their potential use as experimental carriers for intestinal delivery. This is particularly significant for developing oral therapeutics that can withstand the digestive tract. Creative Biolabs offers Grapefruit-derived EVs to support such research. Garlic-derived EVs are being studied for their molecular cargo and potential effects on inflammatory, microbial, and immune-related pathways, generating interest in their use as experimental systems for studying plant-derived bioactive delivery and immunomodulatory mechanisms. These can be sourced via Garlic-derived EVs.
The implications of this expansion are broad. By providing end-to-end support—from isolation and purification of crude plant extracts to multi-dimensional characterization (NTA, TEM, WB), experimental cargo loading (such as encapsulating small molecules, siRNAs, and peptides), and subsequent in vitro and in vivo biological activity assessments—Creative Biolabs lowers the technical barriers for researchers entering this field. This could accelerate the translation of plant-derived EVs from basic research to preclinical studies, potentially leading to novel drug delivery systems and therapeutics. As the scientific community continues to explore the therapeutic potential of PDEVs, comprehensive service platforms like this will be crucial for validating findings and fostering innovation. For more information on plant-derived EV research services, visit https://www.creative-biolabs.com/exosome/.
